5-HT1A receptor: its role in the regulation of different kinds of behavior
https://doi.org/10.18699/VJ16.135
Abstract
Brain serotonin (5-HT) is known to be involved in the control of a wide range of physiological functions as well as of different kinds of behavior. Such polyfunctionality of 5-HT is mediated by numerous 5-HT receptors. Currently, 14 different 5-HT receptor subtypes expressed in the mammals have been identified. The 5-HT1А receptor is one of the most extensively characterised members of the serotonin receptor family. Increased interest to the 5-HT1А receptor is based on (1) a key role in the autoregulation of the brain serotonergic system due to the postsynaptic and presynaptic localization, (2) a great body of data demonstrating implication of 5-HT1А receptor in the control of various physiological functions (3) involvement of 5-HT1А receptors in the mechanisms of depression, anxiety and suicide. The review describes literature and original data on factors affecting the expression and functional activity of 5-HT1А receptors and the involvement of 5-HT1А receptors in the regulation of normal and pathological behavior. The structure of the 5-HT1А receptor gene is described and new data on the posttranslational regulation of 5-HT1А receptor functional activity are provided. A special focus was given to the interaction between 5-HT1А and 5-HT7 receptors followed by heterodimer formation and the role of heterodimerization in the functional inactivation of the 5-HT1А receptor. The implication of 5-HT1А receptors in the regulation of aggressive behavior, catalepsy, anxiety, depression and hibernation was shown. Special attention is focused on the involvement of 5-HT1А receptors in the regulation of 1) fear-induced aggression towards man – the basis of domestication, 2) intermale aggression underling asocial behavior in men, 3) depression and in the mechanism of antidepressant action. The described data extend the idea on the 5-HT1А receptor as a key player in the brain 5-HT system.
About the Authors
V. S. NaumenkoRussian Federation
E. G. Ponimaskin
Russian Federation
N. K. Popova
Russian Federation
References
1. Abe M., Nakai H., Tabata R., Saito K., Egawa M. Effect of 5-[3-[((2S)-1,4- benzodioxan-2-ylmethyl)amino]propoxy]-1,3-benzodioxole HCl (MKC-242), a novel 5- HT1A-receptor agonist, on aggressive behavior and marble burying behavior in mice. Jpn. J. Pharmacol. 1998;76(3):297-304.
2. Aghajanian G. Electrophysiology of serotonin receptor subtypes and signal transduction pathways. Psychopharmacology: The Fourth Generation of Progress. Eds F.R. Bloom, D.J. Kupfer. N.Y.: Raven Press, 1995;1451-1459.
3. Albert P.R., Lemonde S. 5-HT1A receptors, gene repression, and depression: guilt by association. Neuroscientist. 2004;10(6):575-593.
4. Albert P.R., Sajedi N., Lemonde S., Ghahremani M.H. Constitutive G(i2)-dependent activation of adenylyl cyclase type II by the 5-HT1A receptor. Inhibition by anxiolytic partial agonists. J. Biol. Chem. 1999;274(50):35469-35474.
5. Albert P.R., Zhou Q.Y., Van Tol H.H., Bunzow J.R., Civelli O. Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene. J. Biol. Chem. 1990;265(10): 5825-5832.
6. Amir S., Brown Z.W., Amit Z., Ornstein K. Body pinch induces long lasting cataleptic like immobility in mice: behavioral characterization and the effect of naloxone. Life Sci. 1981;28(10):1189-1194.
7. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 1999;38(8):1083-1152.
8. Barykina N.N., Chepkasov I.L., Alehina T.A., Kolpakov V.G. Selection of Wistar rats for the predisposition to catalepsy. Genetika = Genetics (Moscow). 1983;19:2014- 2021.
9. Belyaev D.K. The Wilhelmine E. Key 1978 invitational lecture. Destabilizing selection as a factor in domestication. J. Hered. 1979;70(5): 301-308.
10. Belyaev D.K., Borodin P.M. Vlijanie stressa na nasledstvennuju izmenchivost i ego rol v jevoljucii [The Effect of Stress on the Hereditary Variability and its Role in the Evolution]. Leningrad, LGU, 1982:35-59.
11. Blanchard D.C., Herbert M., Blanchard R.J. Continuity versus (Political) Correctness: Animal Models and Human Aggression. Animal Models of Human Emotion and Cognition. (Eds M. Haug, R.E. Whalen, D.C. Washington). American Psychological Association, 1999;297-316.
12. Blier P., Ward N.M. Is there a role for 5-HT1A agonists in the treatment of depression? Biol. Psychiatry. 2003;53(3):193-203.
13. Boutrel B., Monaca C., Hen R., Hamon M., Adrien J. Involvement of 5-HT1A receptors in homeostatic and stress-induced adaptive regulations of paradoxical sleep: studies in 5-HT1A knock-out mice. J. Neurosci. 2002;22(11):4686-4692.
14. Broekkamp C.L., Oosterloo S.K., Berendsen H.H., van Delft A.M. Effect of metergoline, fenfluramine, and 8-OHDPAT on catalepsy induced by haloperidol or morphine. Naunyn Schmiedebergs Arch. Pharmacol. 1988;338(2):191-195.
15. Brunner H.G., Nelen M., Breakefield X.O., Ropers H.H., van Oost B.A. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science. 1993;262(5133): 578-580.
16. Cases O., Seif I., Grimsby J., Gaspar P., Chen K., Pournin S., Muller U., Aguet M., Babinet C., Shih J.C. De Maeyer E.. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science. 1995;268(5218):1763- 1766.
17. Charest A., Wainer B.H., Albert P.R. Cloning and differentiation-induced expression of a murine serotonin1A receptor in a septal cell line. J. Neurosci. 1993;13(12):5164-5171.
18. Clotfelter E.D., O’Hare E.P., McNitt M.M., Carpenter R.E., Summers C.H. Serotonin decreases aggression via 5-HT1A receptors in the fighting fish Betta splendens. Pharmacol. Biochem. Behav. 2007;87(2):222-231.
19. Creti P., Capasso A., Grasso M., Parisi E. Identification of a 5-HT1A receptor positively coupled to planarian adenylate cyclase. Cell Biol. Int. Rep. 1992;16(5):427-432.
20. D’Eath R.B., Ormandy E., Lawrence A.B., Sumner B.E., Meddle S.L. Resident-intruder trait aggression is associated with differences in lysine vasopressin and serotonin receptor 1A (5-HT1A) mRNA expression in the brain of pre-pubertal female domestic pigs (Sus scrofa). J. Neuroendocrinol. 2005;17(10):679-686.
21. Dacks A.M., Dacks J.B., Christensen T.A., Nighorn A.J. The cloning of one putative octopamine receptor and two putative serotonin receptors from the tobacco hawkmoth, Manduca sexta. Insect Biochem. Mol. Biol. 2006;36(9):741-747.
22. De Boer S.F., Lesourd M., Mocaer E., Koolhaas J.M. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2- dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635. J. Pharmacol. Exp. Ther. 1999;288(3):1125-1133.
23. De Boer S.F., Lesourd M., Mocaer E., Koolhaas J.M. Somatodendritic 5-HT(1A) autoreceptors mediate the anti-aggressive actions of 5-HT(1A) receptor agonists in rats: an ethopharmacological study with S-15535, alnespirone, and WAY-100635. Neuropsychopharmacology. 2000;23(1):20-33.
24. De Vry J. 5-HT1A receptor agonists: recent developments and controversial issues. Psychopharmacology (Berl.). 1995;121(1):1-26.
25. Deng D.R., Djalali S., Holtje M., Grosse G., Stroh T., Voigt I., Kusserow H., Theuring F., Ahnert-Hilger G., Hortnagl H. Embryonic and postnatal development of the serotonergic raphe system and its target regions in 5-HT1A receptor deletion or overexpressing mouse mutants. Neuroscience. 2007;147(2):388-402.
26. Dixon A.K. Ethological strategies for defence in animals and humans: their role in some psychiatric disorders. Br. J. Med. Psychol. 1998;71(Pt 4):417-445.
27. Drevets W.C., Thase M.E., Moses-Kolko E.L., Price J., Frank E., Kupfer D.J., Mathis C. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl. Med. Biol. 2007;34(7):865-877.
28. Edwards D.H., Kravitz E.A. Serotonin, social status and aggression. Curr. Opin. Neurobiol. 1997;7(6):812-819.
29. Estrada-Camarena E., Fernandez-Guasti A., Lopez-Rubalcava C. Participation of the 5- HT1A receptor in the antidepressant-like effect of estrogens in the forced swimming test. Neuropsychopharmacology. 2006;31(2):247-255.
30. Evrard A., Malagie I., Laporte A.M., Boni C., Hanoun N., Trillat A.C., Seif I., De Maeyer E., Gardier A., Hamon M., Adrien J. Altered regulation of the 5-HT system in the brain of MAO-A knock-out mice. Eur. J. Neurosci. 2002;15(5):841-851.
31. Fargin A., Raymond J.R., Lohse M.J., Kobilka B.K., Caron M.G., Lefkowitz R.J. The genomic clone G-21 which resembles a betaadrenergic receptor sequence encodes the 5- HT1A receptor. Nature. 1988;335(6188):358-360.
32. Fricchione G.L. Neuroleptic catatonia and its relationship to psychogenic catatonia. Biol. Psychiatry. 1985;20(3):304-313.
33. Fuller R.W. Role of serotonin in therapy of depression and related disorders. J. Clin. Psychiatry. 1991;52(Suppl):52-57.
34. Gerhardt C.C., van Heerikhuizen H. Functional characteristics of heterologously expressed 5-HT receptors. Eur. J. Pharmacol. 1997; 334(1):1-23.
35. Goodwin G.M., De Souza R.J., Green A.R., Heal D.J. The pharmacology of the behavioural and hypothermic responses of rats to 8-hydroxy- 2-(di-n- propylamino)tetralin (8-OH-DPAT). Psychopharmacology (Berl.). 1987;91(4):506-511.
36. Haleem D.J., Shireen E., Haleem M.A. Somatodendritic and postsynaptic serotonin-1A receptors in the attenuation of haloperidolinduced catalepsy. Progr. Neuropsychopharmacol. Biol. Psychiatry. 2004;28(8):1323-1329.
37. Hammer R.P., Jr., Hori K.M., Blanchard R.J., Blanchard D.C. Domestication alters 5- HT1A receptor binding in rat brain. Pharmacol. Biochem. Behav. 1992;42(1):25-28.
38. Handley S.L. 5-Hydroxytryptamine pathways in anxiety and its treatment. Pharmacol. Ther. 1995;66(1):103-148.
39. Hansenne M., Pitchot W., Pinto E., Reggers J., Scantamburlo G., Fuchs S., Pirard S., Ansseau M. 5-HT1A dysfunction in borderline personality disorder. Psychol. Med. 2002;32(5):935-941.
40. Hassanain M., Bhatt S., Siegel A. Differential modulation of feline defensive rage behavior in the medial hypothalamus by 5-HT1A and 5-HT2 receptors. Brain Res. 2003;981(1-2):201-209.
41. Heisler L.K., Chu H.M., Brennan T.J., Danao J.A., Bajwa P., Parsons L.H., Tecott L.H. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc. Natl Acad. Sci. USA. 1998;95(25):15049-15054.
42. Hill R.H., Svensson E., Dewael Y., Grillner S. 5-HT inhibits N-type but not L-type Ca(2+) channels via 5-HT1A receptors in lamprey spinal neurons. Eur. J. Neurosci. 2003;18(11):2919-2924.
43. Hirvonen J., Karlsson H., Kajander J., Lepola A., Markkula J., Rasi-Hakala H., Nagren K., Salminen J.K., Hietala J. Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. Int. J. Neuropsychopharmacology.2008;11(4):465-476.
44. Hjorth S. Hypothermia in the rat induced by the potent serotoninergic agent 8-OH-DPAT. J. Neural. Transm. 1985;61(1-2):131-135.
45. Hsiung S.C., Adlersberg M., Arango V., Mann J.J., Tamir H., Liu K.P. Attenuated 5-HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase. J. Neurochem. 2003;87(1):182-194.
46. Humphrey P.P., Barnard E.A. International Union of Pharmacology. XIX. The IUPHAR receptor code: a proposal for an alphanumeric classification system. Pharmacol. Rev. 1998;50(2):271-277.
47. Humphrey P.P., Hartig P., Hoyer D. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol. Sci. 1993;14(6):233-236.
48. Kaufman J., Sullivan G.M., Yang J., Ogden R.T., Miller J.M., Oquendo M.A., Mann J.J., Parsey R.V., DeLorenzo C. Quantification of the serotonin 1A receptor using PET: identification of a potential biomarker of major depression in males. Neuropsychopharmacology. 2015;40(7):1692-1699.
49. Kobe F., Guseva D., Jensen T.P., Wirth A., Renner U., Hess D., Muller M., Medrihan L., Zhang W., Zhang M., Braun K., Westerholz S., Herzog A., Radyushkin K., El-Kordi A., Ehrenreich H., Richter D.W., Rusakov D.A., Ponimaskin E. 5-HT7R/G12 signaling regulates neuronal morphology and function in an age-dependent manner. J. Neurosci. 2012;32(9):2915-2930.
50. Kobilka B.K., Frielle T., Collins S., Yang-Feng T., Kobilka T.S., Francke U., Lefkowitz R.J., Caron M.G. An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature. 1987;329(6134):75-79.
51. Kondaurova E.M., Bazovkina D.V., Kulikov A.V., Popova N.K. Selective breeding for catalepsy changes the distribution of microsatellite D13Mit76 alleles linked to the 5-HT serotonin receptor gene in mice. Genes Brain Behav. 2006;5(8):596-601.
52. Korte S.M., Meijer O.C., de Kloet E.R., Buwalda B., Keijser J., Sluyter F., van Oortmerssen G., Bohus B. Enhanced 5-HT1A receptor expression in forebrain regions of aggressive house mice. Brain Res. 1996;736(1-2):338-343.
53. Kulikov A.V., Bazovkina D.V. Testing linkage hypotheses in hybrid analysis of alternatively distributed behavioral traits with incomplete penetrance. Genetika = Genetics (Moscow). 2003;39(8):1066-1072.
54. Kulikov A.V., Bazovkina D.V., Moisan M-P., Mormede P. The mapping of the gene of susceptibility to catalepsy in mice using polymorphic microsatellite markers. Dokl. Biol. Sci. 2003;393:531-534.
55. Kulikov A.V., Bazovkina D.V., Moisan M-P., Mormede P. The mapping of the gene of susceptibility to catalepsy in mice using polymorphic microsatellite markers. Doklady Akademii nauk = Proceedings of the Russian Academy of Sciences. 2003;393(1):134-137.
56. Lai M.K., Tsang S.W., Francis P.T., Esiri M.M., Keene J., Hope T., Chen C.P. Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease. Brain Res. 2003;974(1-2):82-87.
57. Lanzenberger R.R., Mitterhauser M., Spindelegger C., Wadsak W., Klein N., Mien L.K., Holik A., Attarbaschi T., Mossaheb N., Sacher J., Geiss-Granadia T., Kletter K., Kasper S., Tauscher J. Reduced serotonin-1A receptor binding in social anxiety disorder. Biol. Psychiatry. 2007;61(9):1081-1089.
58. Lemonde S., Du L., Bakish D., Hrdina P., Albert P.R. Association of the C(-1019)G 5- HT1A functional promoter polymorphism with antidepressant response. Int. J. Neuropsychopharmacol. 2004;7(4): 501-506.
59. Lemonde S., Turecki G., Bakish D., Du L., Hrdina P.D., Bown C.D., Sequeira A., Kushwaha N., Morris S.J., Basak A., Ou X.M., Albert P.R. Impaired repression at a 5- hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J. Neurosci. 2003;23(25):8788-8799.
60. Lopez J.F., Chalmers D.T., Little K.Y., Watson S.J. A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol. Psychiatry. 1998;43(8): 547-573.
61. Maurel J.L., Autin J.M., Funes P., Newman-Tancredi A., Colpaert F., Vacher B. High- efficacy 5-HT1A agonists for antidepressant treatment: a renewed opportunity. J. Med. Chem. 2007;50(20):5024-5033.
62. Maxson A.C. Aggression: concepts and methods relevant to genetic analyses in mice and humans. Neurobehavioral genetics. Methods and applications. (Eds B.C. Jones, P. Mormede). N.W., Boca Raton, Florida: CRC Press LLC, 1999;293-300.
63. Mendoza D.L., Bravo H.A., Swanson H.H. Antiaggressive and anxiolytic effects of gepirone in mice, and their attenuation by WAY 100635. Pharmacol. Biochem. Behav. 1999;62(3):499-509.
64. Miyata S., Shimoi T., Hirano S., Yamada N., Hata Y., Yoshikawa N., Ohsawa M., Kamei J. Effects of serotonergic anxiolytics on the freezing behavior in the elevated open-platform test in mice. J. Pharmacol. Sci. 2007;105(3):272-278.
65. Monti J.M., Jantos H. Effects of the 5-HT1A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat. Behav. Brain Res. 2004;151(1-2):159-166.
66. Moyer K.B. Kinds of aggression and their physiological basis. Commun. Behav. Biol. 1968;2:65-87.
67. Naumenko V.S., Ivanova E.A., Kulikov A.V., Popova N.K. Effect of monoamine oxidase A knockout on the expression of 5-HTlA receptors. Dokl. Biol. Sci. 2005;402:205-207.
68. Naumenko V.S., Ivanova E.A., Kulikov A.V., Popova N.K. Effect of monoamine oxidase A knockout on the expression of 5-HTlA receptors. Doklady Akademii nauk = Proceedings of the Russian Academy of Sciences. 2005;402(2):282-285.
69. Naumenko V.S., Kondaurova E.M., Kulikov A.V., Popova N.K. Effect of selection for a high predisposition to catalepsy on the functional activity of 5-HT1A receptors and expression of their gene. Dokl. Biol. Sci. 2006;409:299-301
70. Naumenko V.S., Kondaurova E.M., Kulikov A.V., Popova N.K. Effect of selection for high predisposition to catalepsy on the functional activity of 5-HT1A receptors and expression of their gene. Doklady Akademii nauk = Proceedings of the Russian Academy of Sciences. 2006;409:133-135.
71. Naumenko V.S., Kondaurova E.M., Popova N.K. Central 5-HT3 receptor-induced hypothermia in mice: interstrain differences and comparison with hypothermia mediated via 5-HT1A receptor. Neurosci. Lett. 2009;465(1):50-54.
72. Naumenko V.S., Kondaurova E.M., Popova N.K. On the role of brain 5-HT7 receptor in the mechanism of hypothermia: comparison with hypothermia mediated via 5-HT1A and 5- HT3 receptor. Neuropharmacology. 2011;61(8):1360-1365.
73. Naumenko V.S., Kozhemyakina R.V., Plyusnina I.F., Kulikov A.V., Popova N.K. Serotonin 5-HT1A receptor in infancy-onset aggression: comparison with genetically defined aggression in adult rats. Behav. Brain. Res. 2013;243:97-101.
74. Naumenko V.S., Popova N.K., Lacivita E., Leopoldo M., Ponimaskin E.G. Interplay between serotonin 5-HT1A and 5-HT7 receptors in depressive disorders. CNS Neurosci. Ther. 2014;20(7):582-590.
75. Naumenko V.S., Tkachev S.E., Kulikov A.V., Semenova T.P., Amerhanov Z.G., Smirnova N.P., Popova N.K. The brain 5-HT1A receptor gene expression in hibernation. Genes. Brain. Behav. 2008;7(3): 300-305.
76. Nikulina E.M., Borodin P.M., Popova N.K. Change in certain forms of aggressive behavior and the concentration of monoamines in the brain during selection of wild rats for taming. Zhurnal vysshej nervnoj dejatelnosti im. I.P. Pavlova = I.P. Pavlov Journal of Higher Nervous Activity. 1985а;35(4):703-709.
77. Nikulina E.M., Trapezov O.V., Popova N.K. Concentration of monoamines in the brain of minks differing in their reaction to man. Zhurnal vysshej nervnoj dejatelnosti im. I.P. Pavlova = I.P. Pavlov Journal of Higher Nervous Activity. 1985b;35(6):1142- 1146.
78. Oakey R.J., Caron M.G., Lefkowitz R.J., Seldin M.F. Genomic organization of adrenergic and serotonin receptors in the mouse: linkage mapping of sequence-related genes provides a method for examining mammalian chromosome evolution. Genomics. 1991;10(2): 338-344.
79. Olivier B., Mos J., van Oorschot R., Hen R. Serotonin receptors and animal models of aggressive behavior. Pharmacopsychiatry. 1995;28(Suppl. 2):80-90.
80. Ou X.M., Jafar-Nejad H., Storring J.M., Meng J.H., Lemonde S., Albert P.R. Novel dual repressor elements for neuronal cell-specific transcription of the rat 5-HT1A receptor gene. J. Biol. Chem. 2000; 275(11):8161-8168.
81. Ou X.M., Storring J.M., Kushwaha N., Albert P.R. Heterodimerization of mineralocorticoid and glucocorticoid receptors at a novel negative response element of the 5-HT1A receptor gene. J. Biol Chem. 2001;276(17):14299-14307.
82. Overstreet D.H., Commissaris R.C., De La Garza R., 2nd, File S.E., Knapp D.J., Seiden L.S. Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models. Stress. 2003;6(2):101-110.
83. Parks C.L., Robinson P.S., Sibille E., Shenk T., Toth M. Increased anxiety of mice lacking the serotonin1A receptor. Proc. Natl Acad. Sci. USA. 1998;95(18):10734- 10739.
84. Peroutka S.J., Howell T.A. The molecular evolution of G protein-coupled receptors: focus on 5-hydroxytryptamine receptors. Neuropharmacology. 1994;33(3-4):319-324.
85. Plyusnina I., Oskina I. Behavioral and adrenocortical responses to open-field test in rats selected for reduced aggressiveness toward humans. Physiol. Behav. 1997;61(3):381-385.
86. Plyusnina I.Z., Oskina I.N., Tibeikina M.A., Popova N.K. Cross-fostering effects on weight, exploratory activity, acoustic startle reflex and corticosterone stress response in Norway gray rats selected for elimination and for enhancement of aggressiveness towards human. Behav. Genet. 2009;39(2):202-212.
87. Popa D., El Yacoubi M., Vaugeois J.M., Hamon M., Adrien J. Homeostatic regulation of sleep in a genetic model of depression in the mouse: effects of muscarinic and 5- HT1A receptor activation. Neuropsychopharmacology. 2006;31(8):1637-1646.
88. Popova N.K. Serotonin in genetically determined types of defensive behavior. Zh. Vyssh. Nerv. Deiat. im. I.P. Pavlova. 1997;47(2): 350-357.
89. Popova N.K. Serotonin in genetically determined types of defensive behavior. Zhurnal vysshej nervnoj dejatelnosti im. I.P. Pavlova = I.P. Pavlov Journal of Higher Nervous Activity. 1997;47:93-97.
90. Popova N. Brain serotonin in genetically defined defensive behaviour. Complex Brain Functions: Conceptual Advances in Russian Neuroscience. (Eds R. Millar, A. Ivanitsky, P. Balaban). London: Harwood Press, 1999;307-329.
91. Popova N.K. The role of brain serotonin in the expression of genetically determined defensive behavior. Genetika = Genetics (Moscow). 2004;40(6):770-778.
92. Popova N.K., Avgustinovich D.F., Kolpakov V.G., Plyusnina I.Z. Specific [3H]8-OH- DPAT binding in brain regions of rats genetically predisposed to various defense behavior strategies. Pharmacol. Biochem. Behav. 1998;59(4):793-797.
93. Popova N.K., Gilinsky M.A., Amstislavskaya T.G., Morosova E.A., Seif I., De Maeyer E. Regional serotonin metabolism in the brain of transgenic mice lacking monoamine oxidase A. J. Neurosci. Res. 2001;66(3):423-427.
94. Popova N.K., Kulikov A.V., Nikulina E.M., Kozlachkova E.Y., Maslova G.B. Serotonin metabolism and serotonergic receptors in Norway rats selected for low aggressiveness to man. Aggressive Behav. 1991a;17:207-213.
95. Popova N.K. Naumenko V.S. Polymorphism in 5-HT receptors as the background of serotonin functional diversity. Rossijskij fiziologicheskij zhurnal im. I.M. Sechenova = Russian Jounal of Physiology. 2010;96(8):778-786.
96. Popova N.K., Naumenko V.S. 5-HT1A receptor as a key player in the brain 5-HT system. Rev. Neurosci. 2013;24(2):191-204.
97. Popova N.K., Naumenko E.V., Kolpakov V.G. Serotonin i povedenie [Serotonin and Behavior]. Novosibirsk, Nauka, 1978.
98. Popova N.K., Naumenko V.S., Plyusnina I.Z., Kulikov A.V. Reduction in 5-HT1A receptor density, 5-HT1A mRNA expression, and functional correlates for 5-HT1A receptors in genetically defined aggressive rats. J. Neurosci. Res. 2005;80(2):286- 292.
99. Popova N.K., Voitenko N.N., Kulikov A.V., Avgustinovich D.F. Evidence for the involvement of central serotonin in mechanism of domestication of silver foxes. Pharmacol. Biochem. Behav. 1991b; 40(4):751-756.
100. Pruus K., Skrebuhhova-Malmros T., Rudissaar R., Matto V., Allikmets L. 5-HT1A receptor agonists buspirone and gepirone attenuate apomorphine-induced aggressive behaviour in adult male Wistar rats. J. Physiol. Pharmacol. 2000;51(4 Pt 2):833-846.
101. Rakel R.E. Long-term buspirone therapy for chronic anxiety: a multicenter international study to determine safety. South Med. J. 1990; 83(2):194-198.
102. Ramboz S., Oosting R., Amara D.A., Kung H.F., Blier P., Mendelsohn M., Mann J.J., Brunner D., Hen R. Serotonin receptor 1A knockout: an animal model of anxiety- related disorder. Proc. Natl Acad. Sci. USA. 1998;95(24):14476-14481.
103. Raymond J.R. Protein kinase C induces phosphorylation and desensitization of the human 5-HT1A receptor. J. Biol. Chem. 1991;266(22): 14747-14753.
104. Renner U., Zeug A., Woehler A., Niebert M., Dityatev A., Dityateva G., Gorinski N., Guseva D., Abdel-Galil D., Frohlich M., Doring F., Wischmeyer E., Richter D.W., Neher E., Ponimaskin E.G. Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking. J. Cell. Sci. 2012;125(Pt 10):2486-2499.
105. Ricci L.A., Rasakham K., Grimes J.M., Melloni R.H., Jr. Serotonin-1A receptor activity and expression modulate adolescent anabolic/androgenic steroid-induced aggression in hamsters. Pharmacol. Biochem.Behav. 2006;85(1):1-11.
106. Robinson D.S., Alms D.R., Shrotriya R.C., Messina M., Wickramaratne P. Serotonergic anxiolytics and treatment of depression. Psychopathology. 1989;22(Suppl. 1):27-36.
107. Sanberg P.R., Bunsey M.D., Giordano M., Norman A.B. The catalepsy test: its ups and downs. Behav. Neurosci. 1988;102(5):748-759.
108. Saudou F., Hen R. 5-Hydroxytryptamine receptor subtypes: molecular and functional diversity. Adv. Pharmacol. 1994;30:327-380.
109. Sawiniec J., Borkowski K., Ginalska G., Lewandowska-Stanek H. Association between 5- hydroxytryptamine 1A receptor gene polymorphism and suicidal behavior. Przegl. Lek. 2007;64(4-5):208-211.
110. Serretti A., Artioli P., De Ronchi D. The 5-HT2C receptor as a target for mood disorders. Expert Opin. Ther. Targets. 2004;8(1):15-23.
111. Shively C.A., Friedman D.P., Gage H.D., Bounds M.C., Brown-Proctor C., Blair J.B., Henderson J.A., Smith M.A., Buchheimer N. Behavioral depression and positron emission tomography-determined serotonin 1A receptor binding potential in cynomolgus monkeys. Arch. Gen. Psychiatry. 2006;63(4):396-403.
112. Sibille E., Arango V., Galfalvy H.C., Pavlidis P., Erraji-Benchekroun L., Ellis S.P., John Mann J. Gene expression profiling of depression and suicide in human prefrontal cortex. Neuropsychopharmacology. 2004;29(2):351-361.
113. Singerman B., Raheja R. Malignant catatonia-a continuing reality. Ann. Clin. Psychiatry. 1994;6(4):259-266.
114. Sperry T.S., Thompson C.K., Wingfield J.C. Effects of acute treatment with 8-OH-DPAT and fluoxetine on aggressive behaviour in male song sparrows (Melospiza melodia morphna). J. Neuroendocrinol. 2003;15(2):150-160.
115. Stein D.J., Miczek K.A., Lucion A.B., de Almeida R.M. Aggressionreducing effects of F15599, a novel selective 5-HT1A receptor agonist, after microinjection into the ventral orbital prefrontal cortex, but not in infralimbic cortex in male mice. Psychopharmacology (Berl.). 2013;230(3):375-387.
116. Storring J.M., Charest A., Cheng P., Albert P.R. TATA-driven transcriptional initiation and regulation of the rat serotonin 5-HT1A receptor gene. J. Neurochem. 1999;72(6):2238-2247.
117. Sun Y.N., Wang T., Wang Y., Han L.N., Li L.B., Zhang Y.M., Liu J. Activation of 5- HT1A receptors in the medial subdivision of the central nucleus of the amygdala produces anxiolytic effects in a rat model of Parkinson’s disease. Neuropharmacology. 2015;95:181-191.
118. Trut L.N. Nekotorye novye dannye po selekcii serebristo-chernyh lisic (Vulpes fulvus Desm.) po svojstvam ih oboronitelnogo povedenija. [Some New Data on Selection of Silver Foxes (Vulpes fulvus Desm.) with Regard to Features of Their Defensive Behavior]. Genetika povedenija [The Genetics of Behavior]. Leningrad, Nauka, 1969.
119. Trut L.N. Ocherki po genetike povedenija [Essays on Behavioral Genetics]. Novosibirsk, Nauka, 1978.
120. Turner J.H., Gelasco A.K., Raymond J.R. Calmodulin interacts with the third intracellular loop of the serotonin 5-hydroxytryptamine1A receptor at two distinct sites: putative role in receptor phosphorylation by protein kinase C. J. Biol. Chem. 2004;279(17):17027-17037.
121. van den Berg L., Kwant L., Hestand M.S., van Oost B.A., Leegwater P.A. Structure and variation of three canine genes involved in serotonin binding and transport: the serotonin receptor 1A gene (htr1A), serotonin receptor 2A gene (htr2A), and serotonin transporter gene (slc6A4). J. Hered. 2005;96(7):786-796.
122. Woehler A., Wlodarczyk J., Ponimaskin E.G. Specific oligomerization of the 5-HT1A receptor in the plasma membrane. Glycoconj J. 2009; 26(6):749-756.
123. Wissink S., Meijer O., Pearce D., van Der Burg B., van Der Saag P.T. Regulation of the rat serotonin-1A receptor gene by corticosteroids. J. Biol. Chem. 2000;275(2):1321-1326.
124. Zhang Y., D’Souza D., Raap D.K., Garcia F., Battaglia G., Muma N.A., Van de Kar L.D. Characterization of the functional heterologous desensitization of hypothalamic 5-HT(1A) receptors after 5-HT(2A) receptor activation. J. Neurosci. 2001;21(20):7919- 7927.
125. Zhuang X., Gross C., Santarelli L., Compan V., Trillat A.C., Hen R. Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors. Neuropsychopharmacology. 1999;21(2 Suppl):52S-60S.
126. Zifa E., Fillion G. 5-Hydroxytryptamine receptors. Pharmacol. Rev. 1992;44(3):401- 458.